RFP
Closing Date:
Novel Drug Discovery Proposals and Small Molecule-based Approaches for Neurodegenerative Disorders

Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing novel therapeutic concepts/targets related to neurodegenerative disorders or genetic neurological diseases. One‑year projects will be funded up to JPY 10,000,000 or equivalent amount, including indirect costs.
Diseases of particular interest: amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, Down’s syndrome with Alzheimer’s disease, cerebral amyloid angiopathy...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile